|
|
Volumn 18, Issue 8, 2016, Pages 512-516
|
|
FDA advisory panel votes to recommend non-adjunctive use of Dexcom G5 mobile CGM
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLUCOSE;
ANTIDIABETIC AGENT;
INSULIN;
BLOOD GLUCOSE METER;
BLOOD GLUCOSE MONITORING;
CONFERENCE PAPER;
FOOD AND DRUG ADMINISTRATION;
G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM;
GLUCOSE BLOOD LEVEL;
HUMAN;
INSULIN DEPENDENT DIABETES MELLITUS;
INTERSTITIAL FLUID;
MOBILE APPLICATION;
MONITOR;
PRIORITY JOURNAL;
REMOTE SENSING;
SMARTPHONE;
ADVISORY COMMITTEE;
AMBULATORY MONITORING;
ANALYSIS;
BLOOD;
CALIBRATION;
CHEMICALLY INDUCED;
DEVICE APPROVAL;
DEVICES;
DRUG MONITORING;
HYPERGLYCEMIA;
HYPOGLYCEMIA;
PATIENT EDUCATION;
PRACTICE GUIDELINE;
QUALITY OF LIFE;
UNITED STATES;
ADVISORY COMMITTEES;
BLOOD GLUCOSE;
BLOOD GLUCOSE SELF-MONITORING;
CALIBRATION;
DEVICE APPROVAL;
DIABETES MELLITUS, TYPE 1;
DRUG MONITORING;
HUMANS;
HYPERGLYCEMIA;
HYPOGLYCEMIA;
HYPOGLYCEMIC AGENTS;
INSULIN;
MONITORING, AMBULATORY;
PATIENT EDUCATION AS TOPIC;
PRACTICE GUIDELINES AS TOPIC;
QUALITY OF LIFE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84983041989
PISSN: 15209156
EISSN: 15578593
Source Type: Journal
DOI: 10.1089/dia.2016.07252.mr Document Type: Conference Paper |
|
Times cited : (39)
|
|
References (0)
|